Form 8-K - Current report:
SEC Accession No. 0001193125-22-142331
Filing Date
2022-05-05
Accepted
2022-05-05 16:17:58
Documents
14
Period of Report
2022-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d350831d8k.htm   iXBRL 8-K 25476
2 EX-99.1 d350831dex991.htm EX-99.1 32091
6 GRAPHIC g350831g0505060221223.jpg GRAPHIC 2077
  Complete submission text file 0001193125-22-142331.txt   188138

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tyra-20220505.xsd EX-101.SCH 2836
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tyra-20220505_lab.xml EX-101.LAB 17979
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tyra-20220505_pre.xml EX-101.PRE 11245
8 EXTRACTED XBRL INSTANCE DOCUMENT d350831d8k_htm.xml XML 3343
Mailing Address 2656 STATE STREET CARLSBAD CA 92008
Business Address 2656 STATE STREET CARLSBAD CA 92008 (619) 728-4760
Tyra Biosciences, Inc. (Filer) CIK: 0001863127 (see all company filings)

EIN.: 831476348 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40800 | Film No.: 22896557
SIC: 2834 Pharmaceutical Preparations